[67] described increased force generation and decreased fatigability of skeletal muscle isolated from rat soleus incubated in a buffer containing 10 mmol/L L-carnitine
Savolitinib (AZD6094/HMPL-504, AstraZeneca, Cambridge, UK), another class I c-MET inhibitor, is currently being studied in multiple tumor types, including central nervous system tumors, RCC, NSCLC, and GI cancers, both as monotherapy and in combination with other targeted and immunotherapy agents
R., Carlsson-Skwirut, C., Andersson, C., Hall, E., Sjgren, B., Holmgren, A., & Jrnvall, H
Melasma is not the same condition as post-acne PIH, which is not the same as solar lentigines, which is not the same as lichen planus pigmentosus
Author Correction: Hepatocellular carcinoma
What questions should I ask my aesthetician